Latisse on GLP-1: Discuss Eyelid Changes Before Starting

If longer lashes are your goal during treatment, include eyelid appearance in the prescribing conversation.

Discuss eyelid shape and eye color

The US label lists postapproval reports of fat loss around the eyes, a deeper eyelid crease and drooping lids. Voluntary reports cannot reliably establish frequency or a causal relationship. The label also warns that increased brown iris pigmentation is likely permanent. [1]

Why mixed studies cannot supply your percentage

A September 2026 review included 45 studies and 7,106 participants; 3,176 had bimatoprost exposure. Treatment contexts included glaucoma, elevated eye pressure and cosmetic use. Its comparative analyses addressed eye-area changes with different prostaglandin medicines; evidence certainty was low or very low. [2]

Most evidence was observational, and recovery varied. These findings do not give a reliable personal risk estimate for someone applying Latisse to the lash line. Glaucoma drops placed into the eye and cosmetic lash-line use are different treatment contexts. Do not transfer a glaucoma comparison into a cosmetic-user percentage. [2]

Bring your eye-medicine list

The label warns that Latisse can interfere with pressure reduction from certain glaucoma medicines. People using prostaglandin eye-pressure treatments should consult their physician before adding it and have eye pressure monitored. Review the full prescribing information together. [1]

These sources do not establish that GLP-1 treatment causes lash loss or that bimatoprost restores facial fullness. For cosmetic tools already in your bag, see our makeup hygiene guide.

Printed book

How to Keep Your Face on GLP-1

$12.95 + free shipping

Order Now

✓ 30 day money back guarantee

This article provides general education, not a diagnosis or an individual treatment plan. Medication information refers to US sources. Discuss medication, nutrition and cosmetic treatment decisions with qualified clinicians.